Epirubicin Hydrochloride 10 mg Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Epirubicin Hydrochloride 10 mg Injection contains epirubicin, an anthracycline cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of several cancers, given as a drip or infusion into a vein, alone or in combination with other medicines, as part of a chemotherapy regimen. It is also described for instillation into the bladder to help prevent the recurrence of bladder cancer after surgery.
Product Information
The following description reflects information associated with epirubicin and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of breast cancer
- Described for the treatment of lung cancer, stomach cancer, pancreatic cancer, ovarian cancer, and other solid tumours
- Described for the treatment of certain lymphomas and leukaemias
- Described for instillation into the bladder to help prevent the recurrence of bladder cancer after surgery
Described Dosage & Administration
- Administered only by a doctor or nurse as a drip or infusion into a vein — not self-administered
- Given alone or with other medicines, at the dose and duration set by the oncology team
- Alcohol should be avoided during treatment, and plenty of water should be taken
Described Side Effects
Commonly described side effects include:
- Low blood platelet count and low white blood cell (neutrophil) count
- Anaemia (low number of red blood cells)
- Nausea, diarrhoea, and inflammation of the digestive tract
- Hair loss
- Absence of menstrual periods
- Fever and hot flushes
- Rash, weight loss, and low energy
Regular blood tests are described as carried out to monitor blood cells and liver, kidney, and heart function. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told about any heart problem or liver disease
- A complete medical history with an updated list of current medicines should be shared with the doctor
- Pregnant women and breastfeeding mothers should consult their doctor beforehand
- Regular blood tests to monitor blood cells and organ function are described as part of treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains epirubicin, an anthracycline chemotherapy medicine used to treat several cancers, given alone or with other medicines, and also instilled into the bladder to help prevent the recurrence of bladder cancer after surgery. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling states it is administered by a doctor or nurse as a drip or infusion into a vein, at the dose and duration set by the oncology team. It is not self-administered.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.